Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Tipmed Revision Hip Prosthesis: 24-Month Post-Market Follow-Up

Official title: A Multicenter, Prospective, Observational, Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System

Run by TIPMED Medical Device Manufacturing Ltd. Co. · NCT07653295 · Data updated 2026-11-12

This PMCF study tests the safety and how well the Tipmed Revision Hip Prosthesis works in adults undergoing hip revision surgery.

More Prosthesis Failure trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment35 (estimated)
SponsorTIPMED Medical Device Manufacturing Ltd. Co.
Industry-sponsored
Locations4 sites (Balıkesir and 3 other locations)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedDecember 31, 2028
Study endsMarch 31, 2029
Registry record updatedJune 18, 2026
Trial IDNCT07653295 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing revision hip arthroplasty with the Tipmed Revision Hip Prosthesis System used in the procedure.

Probably not a fit

Patients with non-revision hip procedures or those not receiving the Tipmed Revision Hip Prosthesis in the revision surgery.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective observational study collects real-world data on the Tipmed Revision Hip Prosthesis System in adults undergoing revision hip arthroplasty. Participants are followed for 24 months after surgery with visits at 6 weeks, 3, 6, 12, 18, and 24 months, during which safety events and functional outcomes are recorded. The Harris Hip Score is used to quantify joint function, and adverse events, implant-related complications, and re-revisions are tracked. Data are gathered from medical records and study visits to assess short- to mid-term safety and performance in routine clinical practice in Turkey. The study plans to enroll 35 eligible participants across multiple centers.

Why it matters

Potential benefit: If successful, the study could provide real-world evidence on the safety and functional performance of the Tipmed Revision Hip Prosthesis, informing clinicians and patients about expected outcomes after revision surgery.

How similar studies have gone: PMCF and post-market follow-up studies in orthopedic implants have demonstrated the value of real-world safety and performance data, though results are device-specific and context-dependent.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals aged 18 years and older,
* Male or female participants,
* Participants who have undergone Revision Hip Arthroplasty (either total revision or partial component revision) for any indication (such as a documented joint failure or prosthesis-related clinical complication),
* Participants in whose revision procedure the Tıpmed™ Revision Hip Prosthesis System components were utilized,
* Participants who are not legally restricted (e.g., military personnel, convicts, or individuals under legal guardianship),
* Participants who have voluntarily signed the written Informed Consent Form (ICF).

Exclusion Criteria:

* Subjects currently participating in any other interventional clinical trial.

Where it's running

  • Republic of Turkey Ministry of Health, Balıkesir Provincial Health Directorate, Atatürk City Hospital
    Balıkesir, Turkey (Türkiye)
    Recruiting
  • Republic of Turkey Ministry of Health, Balıkesir Provincial Health Directorate, Burhaniye State Hospital
    Balıkesir, Turkey (Türkiye)
    Recruiting
  • Dokuz Eylül University Research and Application Hospital
    Izmir, Turkey (Türkiye)
    Recruiting
  • Republic of Turkey Ministry of Health Izmir Provincial Health Directorate Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital
    Izmir, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.